FROM PUBLIC EVENTS · 2026-11-18

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity Advancing late-stage development with first-patient dosing announced in a Phase 3 trial of setidegrasib for KRAS G12D-mutated lung cancer

  • The company announced first-patient dosing in a Phase 3 trial evaluating setidegrasib in KRAS G12D-mutated non-small cell lung cancer that progressed after prior treatment. Source

Roles often seen at this stageClinical & PV · Regulatory affairs · Research & development

Companies at the same stage and their people flow →

← Company library
Japan / Company briefSources checked 2026-10-04

Astellas Pharma

アステラス製薬

Official name · アステラス製薬

Conducts pharmaceutical R&D, including targeted protein degradation candidates in oncology.

setidegrasib

Phase 3

An investigational KRAS G12D protein degrader in a phase 3 comparison with docetaxel for previously treated, progressing KRAS G12D-mutated advanced NSCLC.

Completion reported

The September 24 release announced the first patient dosed in that phase 3 study; it did not separately specify the dosing date.

Official role guide

Research & development (role guide)

Not an individual vacancy

Observed 2026-10-04

Work
Describes basic and nonclinical research, drug-discovery technologies and research advancing candidates toward clinical development.
Experience & requirements
Unconfirmed — The reviewed general role guide does not specify mandatory degree or years of experience.

Information from a role guide does not establish a current vacancy.

Recruitment program

2027年度 新卒入社・博士通年選考

Closed posting

Observed 2026-10-04

Work
Unconfirmed — The current requirements page shows recruitment has ended; individual advertised duties were not verified.
Experience & requirements
Unconfirmed — Detailed eligibility for the closed graduate program is unverified.
Sources & coverage 4

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. アステラス製薬 企業・研究紹介 ↗アステラス製薬 · Published Date unconfirmed · Sources checked 2026-10-03
  2. Setidegrasib 第3相 初回患者投与 ↗Astellas · Published 2026-09-24 · Sources checked 2026-10-03
  3. 創薬研究職 — 仕事の内容 ↗アステラス製薬 · Published Date unconfirmed · Sources checked 2026-10-03
  4. 2027年度 募集要項 ↗アステラス製薬 · Published Date unconfirmed · Sources checked 2026-10-04